<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The most common indications for treatment of patients with <z:e sem="disease" ids="C0033845" disease_type="Disease or Syndrome" abbrv="">pseudotumor cerebri</z:e> are the presence of severe intractable <z:hpo ids='HP_0002315'>headaches</z:hpo> and evidence of <z:hpo ids='HP_0001138'>optic neuropathy</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>The role of the ophthalmologist in following patients with <z:e sem="disease" ids="C0033845" disease_type="Disease or Syndrome" abbrv="">pseudotumor cerebri</z:e> has been to document optic nerve dysfunction in terms of visual field abnormalities or loss of visual acuity </plain></SENT>
<SENT sid="2" pm="."><plain>Macular changes have been described in association with <z:hpo ids='HP_0001085'>papilledema</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>A case of <z:e sem="disease" ids="C0033845" disease_type="Disease or Syndrome" abbrv="">pseudotumor cerebri</z:e> and associated <z:e sem="disease" ids="C0730362" disease_type="Disease or Syndrome" abbrv="">macular disease</z:e> is reviewed to call attention to the need for the ophthalmologist to differentiate between <z:hpo ids='HP_0000572'>visual loss</z:hpo> secondary to <z:hpo ids='HP_0001138'>optic neuropathy</z:hpo> from that of <z:e sem="disease" ids="C0730362" disease_type="Disease or Syndrome" abbrv="">macular disease</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>The case illustrates how quickly <z:e sem="disease" ids="C0730362" disease_type="Disease or Syndrome" abbrv="">macular disease</z:e> can develop </plain></SENT>
<SENT sid="5" pm="."><plain>The management of patients with <z:e sem="disease" ids="C0033845" disease_type="Disease or Syndrome" abbrv="">pseudotumor cerebri</z:e> is discussed </plain></SENT>
</text></document>